IM Cannabis Corp. (IMCC)
NASDAQ: IMCC · Real-Time Price · USD
1.240
-0.070 (-5.34%)
At close: Nov 14, 2025, 4:00 PM EST
1.280
+0.040 (3.23%)
After-hours: Nov 14, 2025, 7:34 PM EST
IM Cannabis Revenue
IM Cannabis had revenue of 13.85M CAD in the quarter ending September 30, 2025, a decrease of -0.23%. This brings the company's revenue in the last twelve months to 52.38M, up 1.92% year-over-year. In the year 2024, IM Cannabis had annual revenue of 54.03M with 10.71% growth.
Revenue (ttm)
52.38M CAD
Revenue Growth
+1.92%
P/S Ratio
0.12
Revenue / Employee
551,389 CAD
Employees
95
Market Cap
6.51M USD
Revenue Chart
* This company reports financials in CAD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 54.03M | 5.23M | 10.71% |
| Dec 31, 2023 | 48.80M | -5.53M | -10.18% |
| Dec 31, 2022 | 54.34M | 20.28M | 59.56% |
| Dec 31, 2021 | 34.05M | 18.16M | 114.30% |
| Dec 31, 2020 | 15.89M | 6.82M | 75.12% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
IMCC News
- 2 days ago - IM Cannabis Reports Third Quarter 2025 Financial Results - PRNewsWire
- 9 days ago - IM Cannabis to Report third Quarter 2025 Financial Results on Thursday, November 13th at 9:00am ET - PRNewsWire
- 17 days ago - IM Cannabis Announces CFO Departure - PRNewsWire
- 18 days ago - Cannabis Investing 2025: 3 Pot Stocks to Watch Before November - MarijuanaStocks
- 23 days ago - IM Cannabis Signs Non-Binding Term Sheet to Acquire 60% Stake in Innovative Quantum Computing Bio Data Company for Up to $54 Million - PRNewsWire
- 2 months ago - IM Cannabis Announces Board Changes and Strategic Decision to Identify Additional Business Opportunities - PRNewsWire
- 2 months ago - IM Cannabis Regains Compliance with Nasdaq Stockholders' Equity Listing Requirement - PRNewsWire
- 3 months ago - IM Cannabis Announces Warrant Amendments and Form F-3 Resale Registration Statement Filing - PRNewsWire